000			03290nam a22003375i 4500
999			_c82223 _d82223
001			82223
003			ES-MaUEC
005			20240611121925.0
007			cr nn 008mamaa
008			150303s2015 gw | s |||| 0|eng d
020			_a9783319111612
024	7		_a10.1007/978-3-319-11161-2 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC632 .L5 _b2015 EB
245	1	0	_aLipid Management : _bFrom Basics to Clinic _cedited by Hussein Yassine
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (XIV, 269 páginas) _b17 ilustraciones, 8 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aBasics of Lipoprotein Metabolism -- Genetics of Lipid Disorders -- Lipid and Inflammation in Atherosclerosis -- Dyslipidemia: Relationship to Insulin Resistance, Fatty Liver, and Sub-clinical atherosclerosis -- Is low HDL cholesterol a marker of a mediator of cardiovascular disease? -- Approach to the patient with lipid disorders -- The Effects of Diet in Hyperlipidemia -- Statins -- Non-alcoholic Fatty Liver Disease (NAFLD): The Lipid Disease of the Liver and the Effect of Statins -- Statins in Heart Failure -- Statins in Chronic Kidney Disease -- Non-statin therapies -- LDL Apheresis -- Dyslipidemia in HIV -- New and Emerging Lipid Therapies.
520	3		_aThis timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease.Â{uF9A0} special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.
650		7	_aLípidos _2embne _9193890 _xMetabolismo _xTrastornos
710	2		_aSpringerLink (Online service) _0Local _9106996
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-11161-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12908630 _b10-10-17 _c10-02-16
942			_2lcc _cLE
945			_aRC632.L5 L575 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11576315 _z06-04-17
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0